These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 26971081)
21. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. Maher D; Mwandumba H J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834 [TBL] [Abstract][Full Text] [Related]
22. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084 [TBL] [Abstract][Full Text] [Related]
23. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution. Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580 [TBL] [Abstract][Full Text] [Related]
24. Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report. Ellis JP; Kalata N; Joekes EC; Kampondeni S; Benjamin LA; Harrison TS; Lalloo DG; Heyderman RS BMC Infect Dis; 2018 Oct; 18(1):520. PubMed ID: 30326861 [TBL] [Abstract][Full Text] [Related]
25. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial. Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383 [TBL] [Abstract][Full Text] [Related]
26. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426 [TBL] [Abstract][Full Text] [Related]
30. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial. Molefi M; Chofle AA; Molloy SF; Kalluvya S; Changalucha JM; Cainelli F; Leeme T; Lekwape N; Goldberg DW; Haverkamp M; Bisson GP; Perfect JR; Letang E; Fenner L; Meintjes G; Burton R; Makadzange T; Ndhlovu CE; Hope W; Harrison TS; Jarvis JN Trials; 2015 Jun; 16():276. PubMed ID: 26081985 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study. Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703 [TBL] [Abstract][Full Text] [Related]
32. An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis. Ngan NTT; Thanh Hoang Le N; Vi Vi NN; Van NTT; Mai NTH; Van Anh D; Trieu PH; Lan NPH; Phu NH; Chau NVV; Lalloo DG; Hope W; Beardsley J; White NJ; Geskus R; Thwaites GE; Krysan D; Tai LTH; Kestelyn E; Binh TQ; Hung LQ; Tung NLN; Day JN Elife; 2021 Sep; 10():. PubMed ID: 34581270 [TBL] [Abstract][Full Text] [Related]
33. Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study. Mbangiwa T; Sturny-Leclère A; Lechiile K; Kajanga C; Boyer-Chammard T; Hoving JC; Leeme T; Moyo M; Youssouf N; Lawrence DS; Mwandumba H; Mosepele M; Harrison TS; Jarvis JN; Lortholary O; Alanio A; Lancet Microbe; 2024 Mar; 5(3):e261-e271. PubMed ID: 38342110 [TBL] [Abstract][Full Text] [Related]
34. Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study. Ahimbisibwe C; Kwizera R; Ndyetukira JF; Kugonza F; Sadiq A; Hullsiek KH; Williams DA; Rhein J; Boulware DR; Meya DB BMC Infect Dis; 2019 Jun; 19(1):558. PubMed ID: 31242860 [TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials. Pullen MF; Hullsiek KH; Rhein J; Musubire AK; Tugume L; Nuwagira E; Abassi M; Ssebambulidde K; Mpoza E; Kiggundu R; Akampurira A; Nabeta HW; Schutz C; Evans EE; Rajasingham R; Skipper CP; Pastick KA; Williams DA; Morawski BM; Bangdiwala AS; Meintjes G; Muzoora C; Meya DB; Boulware DR Clin Infect Dis; 2020 Oct; 71(7):e45-e49. PubMed ID: 31912875 [TBL] [Abstract][Full Text] [Related]
36. A nomogram for predicting paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis among HIV-infected individuals in China. Han X; Liu H; Wang Y; Wang P; Wang X; Yi Y; Li X AIDS Res Ther; 2022 Apr; 19(1):20. PubMed ID: 35473805 [TBL] [Abstract][Full Text] [Related]